A. Bangalee, S. Hanley, and V. Bangalee, “MEDICINE AND THE LAW: Dolutegravir as first-line antiretroviral therapy in South Africa: Beware the one-size-fits-all approach”, S Afr Med J, vol. 112, no. 10, pp. 787–790, Oct. 2022, doi: 10.7196/SAMJ.2022.v112i10.16596.